Biocompatibles adds skin cancer diagnostic tech to oncology portfolio
This article was originally published in Clinica
Executive Summary
UK drug-device combination products developer Biocompatibles has bulked up its cancer products business with the acquisition of a noninvasive melanoma screening technology.